NewAmsterdam Pharma (NASDAQ:NAMS) Stock Quotes, Forecast and News Summary

Q: What sector and industry does NewAmsterdam Pharma (NAMS) operate in?

NewAmsterdam Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

NewAmsterdam Pharma Stock (NASDAQ: NAMS) stock price, news, charts, stock research, profile.

Open	$24.61
Close	$24.97
Volume / Avg.	846.72K / 337.47K
Day Range	$24.40 - $25.15
52 Wk Range	8.64 - 26.35
Market Cap	$2.31B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	80
Short Interest	1.29%
Days to Cover	3.67

Recent News

NewAmsterdam Pharma's Cholesterol Drug To See Blockbuster Sales, Bullish Analyst Sees Massive Upside

Needham initiates coverage on NewAmsterdam Pharma with a Buy rating, highlighting the potential of its cholesterol-lowering drug, obicetrapib.

Vandana Singh

Analyst Confident In NewAmsterdam Pharma's Cholesterol Drug Despite Mixed Reactions To Study Results (CORRECTED)

NewAmsterdam Pharma announced positive topline results from the Phase 3 BROOKLYN trial for obicetrapib, showing a significant LDL-C reduction in HeFH patients. The stock fell 8.35% despite the success, with analysts confident in future trial outcomes.

Vandana Singh

Abbott, Integra LifeSciences And Other Big Stocks Moving Lower In Monday's Pre-Market Session

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Jun

Jul

Aug

Sep

Nov

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.8

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$24.61
Close	$24.97
Volume / Avg.	846.72K / 337.47K
Day Range	$24.40 - $25.15
52 Wk Range	8.64 - 26.35
Market Cap	$2.31B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	80
Short Interest	1.29%
Days to Cover	3.67

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy NewAmsterdam Pharma (NAMS) stock?

You can purchase shares of NewAmsterdam Pharma (NASDAQ:NAMS) through any online brokerage.

View our list of the best stock brokerages

Who are NewAmsterdam Pharma (NAMS) competitors?

Other companies in NewAmsterdam Pharma’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), Twist Bioscience (NASDAQ:TWST), Centessa Pharmaceuticals (NASDAQ:CNTA), SpringWorks Therapeutics (NASDAQ:SWTX) and Protagonist Therapeutics (NASDAQ:PTGX).

What is the forecast, or price target, for NewAmsterdam Pharma (NAMS) stock?

NewAmsterdam Pharma has a consensus price target of $29.25.

What is the current price for NewAmsterdam Pharma (NAMS)?

The stock price for NewAmsterdam Pharma (NASDAQ: NAMS) is $24.97 last updated November 14, 2024 at 4:00 PM EST.

Does NewAmsterdam Pharma (NAMS) pay a dividend?

There are no upcoming dividends for NewAmsterdam Pharma.

When is NewAmsterdam Pharma (NASDAQ:NAMS) reporting earnings?

NewAmsterdam Pharma’s Q4 earnings are confirmed for Thursday, February 6, 2025.

Is NewAmsterdam Pharma (NAMS) going to split?

There is no upcoming split for NewAmsterdam Pharma.

What sector and industry does NewAmsterdam Pharma (NAMS) operate in?

NewAmsterdam Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

NewAmsterdam Pharma

NewAmsterdam Pharma (NAMS) Forecast